FormWeb • naxitamab-gqgk

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

SDS Online Do Not Crush OHS Pharmacy Contact Louisiana Poison Control
(800) 222-1222

Webpage Links

Add Formweb to your mobile device

Android iOS

Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.

Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

Search results for:

naxitamab-gqgk

naxitamab-gqgk

Drug Name	Form	Strength	Infusion Center Available	Restricted	Non-formulary	Ambulatory Available	Interchange	REMS
Danyelza	INJECTION, INTRAVENOUS	40 mg/10 mL (4 mg/mL)

VIEW MORE Antineoplastic Agents
CLASS

Additional Information and Links

Criteria for use:

Oncology
Patient population: Pediatric
Indication: relapsed or refractory high-risk neuroblastoma in patients older than 1 year
Prior authorization

Last updated: Sep. 17, 2021

Black Box Warning: Serious Infusion-Related Reactions and Neurotoxicity

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.